According to clinical data collected from the Severe Chronic Neutropenia International Registry, some patients carrying ELANE mutations can show cyclic neutropenia with a low risk of evolution to AML, whereas other patients exhibit severe neutropenia with high risk of AML [142,143]. This evidence concerns the gene ELANE and Decreased total neutrophil count.